Gritstone Oncology (NASDAQ:GRTS) reported quarterly losses of $(0.35) per share. This is a 2.78 percent increase over losses of $(0.36) per share from the same period last year.
Related Posts
What’s Going On With CrowdStrike Stock Today?
CrowdStrike Holdings Inc (NASDAQ: CRWD) shares are trading higher Wednesday after the company reported better-than-expected financial results and issued guidance above analyst estimates. Several analysts also raised price targets on the stock following the company's report.
Ford’s F-150 Lightning Strikes Twice As Edmunds’ Top-Rated Electric Truck Amid Cybertruck Craze: ‘Honest, Hardworking Pickup’
The reviewer also noted that the F-150 Lightning exceeded its EPA estimate in the EV Range rest it conducted.
